| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 11,058 | 11,242 | 12,032 | 13,216 | | Cost of Revenue | 3,054 | 2,984 | 2,850 | 3,506 | | | Gross Profit | 8,004 | 8,258 | 9,182 | 9,710 | | | Operating Expenses | | Research Development | (2,406) | 1,098 | 1,308 | 1,037 | | Selling General and Administrative | 8,284 | 5,043 | 5,602 | 6,072 | | Non Recurring |
-
|
-
| 880 | 1,235 | | Others | 127 | 187 | 184 | 129 | | | | Total Operating Expenses |
-
|
-
| 7,974 | 8,473 | | | | Operating Income or Loss | 1,999 | 1,930 | 1,208 | 1,237 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 44 | 1,393 |
-
| (409) | | Earnings Before Interest And Taxes | 2,043 | 3,323 | 1,208 | 828 | | Interest Expense |
-
| (492) | 492 | 107 | | Income Before Tax | 2,043 | 3,815 | 716 | 721 | | Income Tax Expense | 1,036 | 1,929 | 405 | 885 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,007 | 1,886 | 311 | (164) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,007 | 1,886 | 311 | (164) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,007 | $1,886 | $311 | ($164) |
|
0.20% Nasdaq 
Income Statement
